Cancer
2019 (Cycle 30)
| Multilayer investigation of resistance mechanisms to WEE1 inhibition in Small Cell Lung Cancer | 2019 (Cycle 30) | $207,300 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Determining How the Intratumoral Environment Confers Stemness in Lung Cancer | 2019 (Cycle 30) | $166,350 |
| University of California, Santa Cruz | Dissertation Awards | |
| Inhibiting a DNA damage control mechanism as a strategy to selectively kill lung cancer cells | 2019 (Cycle 30) | $142,203 |
| University of California, Los Angeles | Dissertation Awards | |
| Identification of Proteins Involved in 5'OH microRNA Production and Protection | 2019 (Cycle 30) | $133,677 |
| University of California, Los Angeles | Dissertation Awards | |
| Role of the E3 ubiquitin ligase RNF125 in pancreatic cancer | 2019 (Cycle 30) | $780,000 |
| Sanford Burnham Prebys Medical Discovery Institute | High Impact Pilot Award | |
| miR-200 MicroRNAs in Lung cancer metastasis | 2019 (Cycle 30) | $191,832 |
| University of California, Berkeley | Postdoctoral Fellowship Awards | |
| Defining the mechanism of dynamic matrix stiffening-driven lung cancer metastasis | 2019 (Cycle 30) | $193,320 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Acetylation of NFkB in NSCLC resistance models | 2019 (Cycle 30) | $162,909 |
| University of California, San Francisco | Dissertation Awards | |
| In situ vaccination of lung cancers with engineered dendritic cells combined with immunotherapy | 2019 (Cycle 30) | $153,894 |
| University of California, Los Angeles | Dissertation Awards | |
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment | 2019 (Cycle 30) | $118,350 |
| Scripps Research Institute | Dissertation Awards | |
| Developing a Novel Cell-free DNA Methylation Assay for Noninvasive Early Detection of Lung Cancer | 2019 (Cycle 30) | $151,350 |
| Stanford University | Dissertation Awards | |
| Novel Immunotherapeutics for Cigarette-Smoking Associated Acute Myeloid Leukemia | 2019 (Cycle 30) | $990,000 |
| University of Southern California | New Investigator Awards | |
| Quantitative and Scalable Tumor Growth Map for Complex Genotypes in Lung Cancer | 2019 (Cycle 30) | $626,000 |
| Stanford University | High Impact Pilot Award | |
| Targeting pH Homeostasis as a Therapeutic Approach for Pancreatic Cancer | 2019 (Cycle 30) | $195,450 |
| Sanford Burnham Prebys Medical Discovery Institute | Postdoctoral Fellowship Awards | |
| Targeting the unique metabolic vulnerabilities of lung cancer | 2019 (Cycle 30) | $199,872 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Cancer cells alter protein synthesis rates to drive tumorigenesis | 2019 (Cycle 30) | $135,738 |
| University of California, San Francisco | Dissertation Awards | |
| Characterization of Smoking-Associated Circulating Tumor DNA (ctDNA) for Lung Cancer | 2019 (Cycle 30) | $151,350 |
| University of California, Los Angeles | Dissertation Awards | |
| Defining regulators of hematopoietic stem cell self-renewal to prevent and treat blood cancers. | 2019 (Cycle 30) | $166,350 |
| University of California, Santa Cruz | Dissertation Awards | |
| Secondhand smoke, past smoking, diet, novel biomarkers and breast cancer metastasis. | 2019 (Cycle 30) | $602,000 |
| San Diego State University Research Foundation | High Impact Pilot Award | |
| The Role of p53-Ninj2 loop in Tumor Progression and Metastasis | 2019 (Cycle 30) | $492,239 |
| University of California, Davis | High Impact Pilot Award | |
| Stem cell signals in the initiation and progression of lung cancer | 2019 (Cycle 30) | $137,550 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
2019 (Cycle 29)
| Targeting aggressive kidney cancer cells deficient in a metabolic enzyme | 2019 (Cycle 29) | $937,500 |
| University of California, Davis | High Impact Research Project Award | |
| Understanding how submucosal gland myoepithelial cells respond to cigarette smoke | 2019 (Cycle 29) | $499,678 |
| University of California, Los Angeles | High Impact Pilot Award | |
| Promoting Tumor Suppressor Activity in Pancreatic Cancer | 2019 (Cycle 29) | $498,469 |
| University of California, San Diego | High Impact Pilot Award | |
| Investigating the Roles of Stromal AR in Prostate Cancer Progression | 2019 (Cycle 29) | $203,280 |
| University of California, Santa Cruz | Postdoctoral Fellowship Awards | |
| Targeting nuclear receptors for the treatment of Pancreatic cancer | 2019 (Cycle 29) | $180,996 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Total Synthesis of Strictosidine, a Precursor to Vinblastine | 2019 (Cycle 29) | $133,677 |
| University of California, Los Angeles | Dissertation Awards | |
| Development of allosteric inhibitors against a molecular target (IKK) induced by cytokines and cigarette smoke | 2019 (Cycle 29) | $921,703 |
| University of California, San Diego | High Impact Research Project Award | |
| Immune mechanisms of FLASH radiotherapy: a new paradigm for lung cancer cure | 2019 (Cycle 29) | $628,421 |
| Stanford University | High Impact Pilot Award | |
| Analysis of bladder cancer precursor formation as a basis for early therapeutic intervention | 2019 (Cycle 29) | $193,320 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Notch3 in Human Lung Adenocarcinoma Pathogenesis and Heterogeneity | 2019 (Cycle 29) | $176,982 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Effects of Smoking on Hematopoietic Stem Cell Dysfunction and Hematologic Cancers | 2019 (Cycle 29) | $122,958 |
| University of California, Irvine | Postdoctoral Fellowship Awards | |
| Impact of splicing factor mutations in the context of tobacco exposure in lung cancer | 2019 (Cycle 29) | $736,710 |
| University of California, Santa Cruz | New Investigator Awards | |
| Combination immuno and metabolic therapy for early-stage lung adenocarcinoma | 2019 (Cycle 29) | $499,756 |
| University of California, Los Angeles | High Impact Pilot Award | |
| Impact of Smoking on Myeloproliferative Neoplasms | 2019 (Cycle 29) | $488,330 |
| University of California, Irvine | High Impact Pilot Award | |
| Constructing a Lung Cancer Map of Drug Resistance States with Single-Cell Analysis | 2019 (Cycle 29) | $138,450 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Implications of stress-induced LPAR4 expression in lung and pancreatic cancers | 2019 (Cycle 29) | $180,996 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Predicting cell-cell interactions in the tumor microenvironment for non-small cell lung carcinoma | 2019 (Cycle 29) | $85,522 |
| Stanford University | Dissertation Awards | |
2019 (Cycle 28)
| Lung cancer cell response to Cdk4/6 inhibition | 2019 (Cycle 28) | $1,047,491 |
| University of California, Santa Cruz | High Impact Research Project Award | |
| Targeting invadopodia in head and neck cancer metastasis | 2019 (Cycle 28) | $498,393 |
| University of California, San Diego | High Impact Pilot Award | |
| MRI-Derived Risk Maps to Predict Prostate Cancer Progression | 2019 (Cycle 28) | $615,860 |
| University of California, San Francisco | High Impact Research Project Award | |
| Large-scale analysis of tumor suppressors in lung cancer | 2019 (Cycle 28) | $173,676 |
| Stanford University | Postdoctoral Fellowship Awards | |
| HER3-biased Sec61 modulators for treatment of cancers | 2019 (Cycle 28) | $173,676 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Stemness suppressors to combat aggressive breast cancers | 2019 (Cycle 28) | $933,655 |
| University of California, San Diego | High Impact Research Project Award | |
| Deciphering p53 Programs in Lung Cancer Suppression | 2019 (Cycle 28) | $611,377 |
| Stanford University | High Impact Pilot Award | |
| Synthesis of Noscapinoids for Treatment of Lung Cancer | 2019 (Cycle 28) | $152,688 |
| University of California, Los Angeles | Dissertation Awards | |
| Total Synthesis of Delavatine A and its Structural Analogues | 2019 (Cycle 28) | $159,924 |
| University of California, Berkeley | Dissertation Awards | |
| Treating NSCLC with Next-Gen RNAi Therapeutics Target | 2019 (Cycle 28) | $498,126 |
| University of California, San Diego | High Impact Pilot Award | |
| Protein Engineering Aids Chimeric Antigen Receptor Design | 2019 (Cycle 28) | $173,676 |
| Beckman Research Institute of the City of Hope | Postdoctoral Fellowship Awards | |
2018 (Cycle 27)
| Studies on SWI/SNF in 3D chromatin structure with viral epis | 2018 (Cycle 27) | $212,207 |
| University of California, Davis | Postdoctoral Fellowship Awards | |
| Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma | 2018 (Cycle 27) | $750,000 |
| University of California, Davis | New Investigator Awards | |
| Targeting Macrophages in the Cancer Stem Cell Niche to Beat Chemoresistance | 2018 (Cycle 27) | $222,407 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| Targeted Degradation of Proliferative E2F in Nicotine-Induced Lung Cancers | 2018 (Cycle 27) | $134,659 |
| University of California, Santa Cruz | Dissertation Awards | |
| Multilevel Study of Lung Cancer Screening Guidelines Implementation | 2018 (Cycle 27) | $886,353 |
| Palo Alto Medical Foundation Research Institute | New Investigator Awards | |
| Structural Mechanism of Rb Inactivation in Lung Adenocarcinoma | 2018 (Cycle 27) | $134,659 |
| University of California, Santa Cruz | Dissertation Awards | |
| Tobacco smoking and inborn genetics: effects on leukemogenesis | 2018 (Cycle 27) | $1,215,889 |
| University of Southern California | High Impact Research Project Award | |
| Genetic dissection of oncogenic Kras signaling in lung cancer | 2018 (Cycle 27) | $184,512 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Oncogenic reprogramming of protein translation by DDX3 inact | 2018 (Cycle 27) | $748,146 |
| University of California, San Francisco | New Investigator Awards | |
| S-Nitrosylation of DNMTs in epigenetic regulation of tumors | 2018 (Cycle 27) | $1,448,303 |
| Scripps Research Institute | High Impact Research Project Award | |
| Uncovering Therapeutic Specificity for Defined Oncogenic KRAS | 2018 (Cycle 27) | $636,561 |
| Stanford University | High Impact Pilot Award | |
2013 (Cycle 22)
| 3rd International RB conference | 2013 (Cycle 22) | $5,000 |
| Stanford University | Special Projects | |
2011 (Cycle 20)
| Proteomic Mapping of Human Lung Tumor Endothelium | 2011 (Cycle 20) | $487,182 |
| Proteomics Research Institute for Systems Medicine | Exploratory/Developmental Award | |
| Dietary effects on tobacco-related lung cancer | 2011 (Cycle 20) | $270,000 |
| University of California, Berkeley | New Investigator Awards | |
| Lung cancer detection by methylation-preserving PCR | 2011 (Cycle 20) | $324,325 |
| University of Southern California | Exploratory/Developmental Award | |
| Sirtuin deacetylase and RAS-dependent cancers | 2011 (Cycle 20) | $420,000 |
| Beckman Research Institute of the City of Hope | Exploratory/Developmental Award | |
| Integrated multi-omics approach to detect early lung cancer | 2011 (Cycle 20) | $744,466 |
| University of California, Davis | Integrated Research Project | |
| Gene-modified Stromal Cell Therapy for Lung Cancer | 2011 (Cycle 20) | $60,498 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| New Diagnosis of Bladder Cancer: Smokers Opportunity to Quit | 2011 (Cycle 20) | $269,936 |
| University of California, Los Angeles | New Investigator Awards | |
| Genome-wide mapping of smoke-induced DNA damage and mutation | 2011 (Cycle 20) | $80,381 |
| Beckman Research Institute of the City of Hope | Exploratory/Developmental Award | |
| Funding Ovarian Cancer Research in California | 2011 (Cycle 20) | $236,953 |
| Ovarian Cancer Research Fund | Special Projects | |
| Snail-Dependent Malignant Conversion of Airway Epithelium | 2011 (Cycle 20) | $266,934 |
| University of California, Los Angeles | New Investigator Awards | |
| Mapping the EphA Receptor Landscape in Lung Cancer | 2011 (Cycle 20) | $98,299 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| SMART: Sequential Motion Adaptation to Improve Lung Cancer RT | 2011 (Cycle 20) | $250,000 |
| University of California, Los Angeles | Exploratory/Developmental Award | |
| A Novel Anti-Cancer Therapy: Inhibition of MUS81-EME1 | 2011 (Cycle 20) | $60,000 |
| University of California, Davis | Dissertation Awards | |
| Genome-wide mapping of smoke-induced DNA damage and mutation | 2011 (Cycle 20) | $334,652 |
| University of Southern California | Exploratory/Developmental Award | |
2010 (Cycle 19)
| SOX-2 knockdown in stem cells prevents lung tumor recurrence | 2010 (Cycle 19) | $473,879 |
| Scripps Research Institute | Exploratory/Developmental Award | |
| Fbxo2: a master regulator of lung cancer metastasis? | 2010 (Cycle 19) | $477,500 |
| The Burnham Institute for Medical Research | Exploratory/Developmental Award | |
| Synthesis of the anti-cancer norcembranoid inelegnolide | 2010 (Cycle 19) | $59,388 |
| University of California, Irvine | Dissertation Awards | |
| Oncogenic Activation Mechanisms of Phosphoinositol-3-Kinase | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Switching off a lung cancer oncogene using small molecules | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Multiple Salivary Biomarkers for Lung Cancer Detection | 2010 (Cycle 19) | $241,103 |
| University of California, Los Angeles | New Investigator Awards | |
| Enhancing mTOR-targeted lung cancer therapy | 2010 (Cycle 19) | $473,879 |
| Scripps Research Institute | Exploratory/Developmental Award | |
| Dynamic Imaging of Sodium Channels in Metastatic Lung Cancer | 2010 (Cycle 19) | $400,000 |
| Stanford University | Exploratory/Developmental Award | |
| Novel Susceptibility Factors in Lung Cancer Evolution | 2010 (Cycle 19) | $400,000 |
| Stanford University | Exploratory/Developmental Award | |
| Inhibiting lung cancer with DNA-binding polyamides | 2010 (Cycle 19) | $44,500 |
| California Institute of Technology | Postdoctoral Fellowship Awards | |
| High resolution imaging & ablation for smoke induced cancer | 2010 (Cycle 19) | $264,219 |
| University of California, Irvine | New Investigator Awards | |
| Reversible Covalent Kinase Inhibitors to Combat Metastasis | 2010 (Cycle 19) | $135,000 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Replication Studies of Minor-Groove DNA Adducts | 2010 (Cycle 19) | $60,000 |
| University of California, Riverside | Dissertation Awards | |
| Smoking-related lung repair and early stage lung cancer | 2010 (Cycle 19) | $135,000 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
2009 (Cycle 18)
| Inflammatory mediators & lung cancer progression | 2009 (Cycle 18) | $59,185 |
| University of California, Los Angeles | Dissertation Awards | |
| Immunotargeting lung cancer | 2009 (Cycle 18) | $487,500 |
| Proteomics Research Institute for Systems Medicine | Exploratory/Developmental Award | |
| Control of cellular self-digestion in lung tumorigenesis | 2009 (Cycle 18) | $135,000 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Paternal Smoking and DNA Methylation in Childhood Leukemia | 2009 (Cycle 18) | $416,758 |
| University of California, San Francisco | California Research Award | |
| Autophagy and cell fate in K-Ras mutant lung cancer cells | 2009 (Cycle 18) | $250,000 |
| University of California, San Francisco | Exploratory/Developmental Award | |
| Molecular therapies against small cell lung cancer | 2009 (Cycle 18) | $60,000 |
| Stanford University | Dissertation Awards | |
| Mechanistic studies of secondhand-smoke carcinogenicity | 2009 (Cycle 18) | $12,610 |
| University of Southern California | New Investigator Awards | |
| Fluorescent Probes for DNA Mismatch Detection | 2009 (Cycle 18) | $59,749 |
| California Institute of Technology | Dissertation Awards | |
| NGAL-dependent Apoptosis Resistance in NSCLC | 2009 (Cycle 18) | $180,000 |
| University of California, Los Angeles | New Investigator Awards | |
| Role of EphA3 receptor mutations in lung cancer | 2009 (Cycle 18) | $477,500 |
| The Burnham Institute for Medical Research | Exploratory/Developmental Award | |
| Novel Therapy Sensitization Strategy for Lung Cancer | 2009 (Cycle 18) | $450,000 |
| Torrey Pines Institute for Molecular Studies | Exploratory/Developmental Award | |
| Genomic Profiles in Tobacco Related Metastatic Oral Cancer | 2009 (Cycle 18) | $30,000 |
| University of California, San Francisco | Dissertation Awards | |
| Genome-specific synthetic lethal targeting in lung cancer | 2009 (Cycle 18) | $400,000 |
| Stanford University | Exploratory/Developmental Award | |
| Inhibition of ERBB2 expression by polyamides in NSCLC | 2009 (Cycle 18) | $59,082 |
| California Institute of Technology | Dissertation Awards | |
| Harnessing the immune system to fight lung cancer | 2009 (Cycle 18) | $117,637 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| Migrating cancer stem cells & early cancer development | 2009 (Cycle 18) | $90,000 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| The role of Wilm's tumor gene 1 in lung cancer | 2009 (Cycle 18) | $135,000 |
| Stanford University | Postdoctoral Fellowship Awards | |
| A new approach to anti-angiogenic therapy in lung cancer | 2009 (Cycle 18) | $407,935 |
| Stanford University | Exploratory/Developmental Award | |
| Mechanistic studies of secondhand-smoke carcinogenicity | 2009 (Cycle 18) | $278,795 |
| Beckman Research Institute of the City of Hope | New Investigator Awards | |
| Quantitative Proteomics of Oral Precancer Progression | 2009 (Cycle 18) | $249,605 |
| University of California, Los Angeles | Exploratory/Developmental Award | |
| Repression of c-Jun oncogene activity in lung cancer | 2009 (Cycle 18) | $58,874 |
| California Institute of Technology | Dissertation Awards | |
| Innate Immune Response to Head and Neck Cancer Stem Cells | 2009 (Cycle 18) | $134,999 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Novel Drugs for Lung Cancer | 2009 (Cycle 18) | $353,998 |
| Veterans Medical Research Foundation | Exploratory/Developmental Award | |
| Acquired apoptotic resistance in 3D lung cancer spheroids | 2009 (Cycle 18) | $135,000 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
2008 (Cycle 17)
| Analysis of the Hippo pathway in lung cancer | 2008 (Cycle 17) | $654,999 |
| Beckman Research Institute of the City of Hope | Research Project Awards | |
| Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer | 2008 (Cycle 17) | $654,674 |
| Beckman Research Institute of the City of Hope | Research Project Awards | |
| Genomic Assay to Identify Targets of Anticancer Therapeutics | 2008 (Cycle 17) | $70,076 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Targeted Imaging and Therapy of Lung Cancer | 2008 (Cycle 17) | $72,144 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Novel Extracellular Sulfatases and Smoke-induced Lung Cancer | 2008 (Cycle 17) | $394,380 |
| University of California, San Francisco | Research Project Awards | |
| Small molecule gene regulation in lung cancer cells | 2008 (Cycle 17) | $31,667 |
| California Institute of Technology | Dissertation Awards | |
| Mechanisms of Tumor Suppressor in Lung Cancer Initiation | 2008 (Cycle 17) | $75,000 |
| University of California, Davis | Postdoctoral Fellowship Awards | |
| Pharmacogenomics of New Generation Platinums in Lung Cancer | 2008 (Cycle 17) | $394,380 |
| University of California, San Francisco | Research Project Awards | |
| Synthesis of the Glaciapyrroles, New Anticancer Agents | 2008 (Cycle 17) | $60,000 |
| University of California, Irvine | Dissertation Awards | |
| Role of lineage-specific oncogene TITF1 in lung cancer | 2008 (Cycle 17) | $74,500 |
| Stanford University | Postdoctoral Fellowship Awards | |
2007 (Cycle 16)
| Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment | 2007 (Cycle 16) | $34,141 |
| University of California, Irvine | Postdoctoral Fellowship Awards | |
| Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $100,481 |
| Sidney Kimmel Cancer Center | Research Project Awards | |
| Fusion proteins that convert VEGF into a cell death factor | 2007 (Cycle 16) | $100,000 |
| University of California, San Francisco | Inno Dev & Exp Awards (IDEAS) | |
| High Resolution OCT for Early Airway Cancer Detection | 2007 (Cycle 16) | $480,636 |
| University of California, Irvine | Research Project Awards | |
| Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $415,463 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Engineering Salmonella for lung cancer therapy | 2007 (Cycle 16) | $187,550 |
| Sidney Kimmel Cancer Center | New Investigator Awards | |
| Targeting the epithelial-mesenchymal transition in HNSCC | 2007 (Cycle 16) | $270,000 |
| University of California, Los Angeles | New Investigator Awards | |
| Targeting anti-apoptotic Bcl-2 family members in lung cancer | 2007 (Cycle 16) | $75,000 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Mechanism of DNA break repair in germline cells | 2007 (Cycle 16) | $75,000 |
| University of California, Davis | Postdoctoral Fellowship Awards | |
| Does nicotine exposure inhibit convective drug delivery? | 2007 (Cycle 16) | $119,692 |
| La Jolla Bioengineering Institute | Inno Dev & Exp Awards (IDEAS) | |
| Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $246,467 |
| Scripps Research Institute | Research Project Awards | |
| Engineering Salmonella for lung cancer therapy | 2007 (Cycle 16) | $104,050 |
| The Burnham Institute for Medical Research | New Investigator Awards | |
| Role of inflammation in lung carcinoma neovascularization | 2007 (Cycle 16) | $75,000 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
2006 (Cycle 15)
| Effect of Sidestream Tobacco Smoke on Parkin Null Mice | 2006 (Cycle 15) | $48,256 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| NF-kB mediated inflammation in tobacco-induced lung cancer | 2006 (Cycle 15) | $420,000 |
| University of California, San Diego | Research Project Awards | |
| Immune Targeted Therapy for Lung Cancer | 2006 (Cycle 15) | $419,500 |
| University of California, Los Angeles | Research Project Awards | |
| How omega-3 fatty acids prevent or slow cancer | 2006 (Cycle 15) | $74,808 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Novel Approaches to Lung Cancer Research | 2006 (Cycle 15) | $189,486 |
| The Burnham Institute for Medical Research | Inno Dev & Exp Awards (IDEAS) | |
| Unraveling lung cancer signaling pathways | 2006 (Cycle 15) | $780,780 |
| Scripps Research Institute | Research Project Awards | |
| Activation and detoxification of lung cancer carcinogens | 2006 (Cycle 15) | $420,000 |
| University of California, San Diego | Research Project Awards | |
| Mechanisms of targeted therapy resistance in lung cancer | 2006 (Cycle 15) | $358,500 |
| University of California, Los Angeles | Research Project Awards | |
2005 (Cycle 14)
| Role of protein phosphatase 2A in lung cancer | 2005 (Cycle 14) | $384,497 |
| University of California, San Diego | Research Project Awards | |
| Role of GL12 in oral mucosa maintenance and carcinogenesis | 2005 (Cycle 14) | $73,485 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Defining mutagenesis pathways in tobacco-related cancer | 2005 (Cycle 14) | $58,993 |
| Scripps Research Institute | Dissertation Awards | |
| A novel, 3-dimensional approach to non-invasive diagnostics | 2005 (Cycle 14) | $99,000 |
| University of California, Irvine | Inno Dev & Exp Awards (IDEAS) | |
| Inhibition of cell death in head and neck cancer cells | 2005 (Cycle 14) | $24,148 |
| University of Southern California | Dissertation Awards | |
| Role of p53-regulated sestrin genes in lung cancer | 2005 (Cycle 14) | $73,500 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Effects of side stream tobacco smoke on DNA deletions | 2005 (Cycle 14) | $58,876 |
| University of California, Los Angeles | Dissertation Awards | |
| Improved chemoradiotherapy of lung cancer | 2005 (Cycle 14) | $659,033 |
| California Pacific Medical Center Research Institute | Research Project Awards | |
| Effect of PDGF inhibition on angiogenesis in lung cancer | 2005 (Cycle 14) | $74,500 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
2004 (Cycle 13)
| COX-2 regulation of vaccination responses in lung cancer | 2004 (Cycle 13) | $379,362 |
| University of California, Los Angeles | Research Project Awards | |
| Transcription factor modification: A role in lung cancer? | 2004 (Cycle 13) | $6,097 |
| California Institute of Technology | Dissertation Awards | |
| IAP Antagonists for lung cancer treatment | 2004 (Cycle 13) | $727,658 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Vitamin A derivatives as antagonists of nicotine effects | 2004 (Cycle 13) | $670,085 |
| The Burnham Institute for Medical Research | Research Project Awards | |
2003 (Cycle 12)
| Targeting Hypoxia-inducible Factor to Treat Lung Cancer | 2003 (Cycle 12) | $509,490 |
| The Burnham Institute for Medical Research | New Investigator Awards | |
| CSF biomarkers of brain metastases from lung cancer | 2003 (Cycle 12) | $100,000 |
| University of California, San Francisco | Inno Dev & Exp Awards (IDEAS) | |
| Peripheral mechanisms of oral cancer pain in a mouse model | 2003 (Cycle 12) | $265,332 |
| University of California, San Francisco | New Investigator Awards | |
| Mechanism of TGF-a shedding in lung cancer development | 2003 (Cycle 12) | $69,600 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Novel Office-Based Device for Imaging Vocal Cord Cancer | 2003 (Cycle 12) | $510,000 |
| University of California, Irvine | Research Project Awards | |
| The role of hCDC4 regulation of cyclin E in lung cancer | 2003 (Cycle 12) | $517,032 |
| Sidney Kimmel Cancer Center | New Investigator Awards | |
| Focal adhesion kinase regulation of Cox-2 in lung cancer | 2003 (Cycle 12) | $74,520 |
| Scripps Research Institute | Postdoctoral Fellowship Awards | |
| Integrins and drug resistance in small cell lung cancer | 2003 (Cycle 12) | $780,144 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Chemotherapeutic inhibition of polysialic acid biosynthesis | 2003 (Cycle 12) | $420,781 |
| University of California, Davis | Research Project Awards | |
| COX-2-dependent modulation of survivin in lung cancer | 2003 (Cycle 12) | $69,500 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| Novel DNA vaccines for the treatment of lung cancer | 2003 (Cycle 12) | $783,900 |
| Scripps Research Institute | Research Project Awards | |
2002 (Cycle 11)
| Total Synthesis of Mitomycin C, an Anti-Cancer Therapeutic | 2002 (Cycle 11) | $59,947 |
| California Institute of Technology | Dissertation Awards | |
| Molecular predictors of oral cancer development | 2002 (Cycle 11) | $419,000 |
| University of California, San Francisco | Research Project Awards | |
| Tobacco carcinogens influence Ah-receptor function | 2002 (Cycle 11) | $43,344 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Total synthesis of cribrostatin 4, a potent anticancer agent | 2002 (Cycle 11) | $74,927 |
| California Institute of Technology | Postdoctoral Fellowship Awards | |
| Novel agents for apoptosis of lung cancer | 2002 (Cycle 11) | $787,977 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Tobacco-altered tissue of the mouth may promote oral cancer | 2002 (Cycle 11) | $113,120 |
| Lawrence Berkeley National Laboratory | Inno Dev & Exp Awards (IDEAS) | |
| Vascular targeting of lung tumors | 2002 (Cycle 11) | $830,563 |
| Sidney Kimmel Cancer Center | Research Project Awards | |
| p53 and p14ARF: Multiple pathways of lung cancer suppression | 2002 (Cycle 11) | $821,050 |
| Sidney Kimmel Cancer Center | Research Project Awards | |
| Enzymatic targets for anticancer therapy | 2002 (Cycle 11) | $267,304 |
| J. David Gladstone Institutes | New Investigator Awards | |
| Involvement of PI3K pathway in bladder cancer invasion | 2002 (Cycle 11) | $224,984 |
| University of California, Davis | New Investigator Awards | |
| Role of protein phosphatase 2A in lung cancer | 2002 (Cycle 11) | $405,795 |
| University of California, San Diego | Research Project Awards | |
2001 (Cycle 10)
| Effect of cigarette smoking on pulmonary metastasis | 2001 (Cycle 10) | $36,236 |
| University of California, Davis | Inno Dev & Exp Awards (IDEAS) | |
| Chemokine-based therapy for lung cancer | 2001 (Cycle 10) | $416,940 |
| University of California, Los Angeles | Research Project Awards | |
| Analysis of a lung tumor supressor gene at 3p21.3 | 2001 (Cycle 10) | $249,438 |
| Beckman Research Institute of the City of Hope | Research Project Awards | |
| The role of P450s in tobacco-mediated lung cancer | 2001 (Cycle 10) | $147,858 |
| La Jolla Institute for Molecular Medicine | New Investigator Awards | |
| Novel regulatory mechanisms for lung cancer growth | 2001 (Cycle 10) | $620,032 |
| Veterans Medical Research Foundation | Research Project Awards | |
| Overcoming drug resistance in small cell lung cancer | 2001 (Cycle 10) | $141,340 |
| The Burnham Institute for Medical Research | Inno Dev & Exp Awards (IDEAS) | |
| Bispecific molecular therapy of small cell lung cancer | 2001 (Cycle 10) | $434,805 |
| University of California, San Diego | Research Project Awards | |
| The role of P450s in tobacco-mediated lung cancer | 2001 (Cycle 10) | $295,815 |
| California Toxicology Research Institute | New Investigator Awards | |
| ZIP kinase and lung cancer | 2001 (Cycle 10) | $65,854 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Functions of IRF-1 and Smad3 interaction in lung cancer | 2001 (Cycle 10) | $69,750 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| PPARs in intestinal and colonic tumorigenesis | 2001 (Cycle 10) | $74,952 |
| Salk Institute for Biological Studies | Postdoctoral Fellowship Awards | |
| Lung cancer therapy with in vivo-generated dendritic cells | 2001 (Cycle 10) | $225,000 |
| University of California, Los Angeles | New Investigator Awards | |
2000 (Cycle 9)
| Improved therapy of lung cancer | 2000 (Cycle 9) | $668,814 |
| California Pacific Medical Center Research Institute | Research Project Awards | |
| New therapy for lung cancer using radioiodide | 2000 (Cycle 9) | $225,000 |
| University of California, Los Angeles | New Investigator Awards | |
| CT imaging to assist diagnosis of solitary pulmonary nodules | 2000 (Cycle 9) | $59,002 |
| University of California, Los Angeles | Research Project Awards | |
| Cytokine gene-modified dendritic cells for lung cancer | 2000 (Cycle 9) | $590,523 |
| University of California, Los Angeles | Research Project Awards | |
| Novel regulatory mechanisms for lung cancer growth | 2000 (Cycle 9) | $100,000 |
| University of California, San Diego | Research Project Awards | |
| Analysis of a candidate lung tumor suppressor gene at 3p21.3 | 2000 (Cycle 9) | $111,910 |
| Beckman Research Institute of the City of Hope | Research Project Awards | |
| Studies of novel antitumor agents for lung carcinoma | 2000 (Cycle 9) | $833,491 |
| University of California, San Diego | Research Project Awards | |
| A new molecular approach for predicting lung cancer | 2000 (Cycle 9) | $75,000 |
| University of California, Irvine | Inno Dev & Exp Awards (IDEAS) | |
| Post-isoprenylation processing steps as anticancer targets | 2000 (Cycle 9) | $1,017,450 |
| J. David Gladstone Institutes | Research Project Awards | |
| Mobilized dendritic cells for lung cancer | 2000 (Cycle 9) | $950,821 |
| Stanford University | Research Project Awards | |
| Transcriptional regulation in normal and neoplastic lung | 2000 (Cycle 9) | $69,350 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| The angiogenic role of interleukin-8 in lung cancer | 2000 (Cycle 9) | $152,785 |
| La Jolla Institute for Molecular Medicine | Inno Dev & Exp Awards (IDEAS) | |
| Novel DNA vaccines for the treatment of lung cancer | 2000 (Cycle 9) | $1,063,300 |
| Scripps Research Institute | Research Project Awards | |
| Siah-family proteins in lung cancer | 2000 (Cycle 9) | $74,560 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Role of Smad protein in growth inhibition of tumor cells | 2000 (Cycle 9) | $474,492 |
| Lawrence Berkeley National Laboratory | Research Project Awards | |
| Chemopreventive strategies against lung cancer recurrence | 2000 (Cycle 9) | $75,000 |
| University of California, Los Angeles | Inno Dev & Exp Awards (IDEAS) | |
| Regulation of MAP kinase signaling pathway in lung cancer | 2000 (Cycle 9) | $84,671 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
1999 (Cycle 8)
| Detection of occult metastases in patients with lung cancer | 1999 (Cycle 8) | $723,842 |
| University of Southern California | Research Project Awards | |
| The role of chloride in tobacco-smoke-induced cancer | 1999 (Cycle 8) | $30,580 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Membrane proteins and TGF-alpha/EGFR: a role in lung cancer? | 1999 (Cycle 8) | $40,436 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| IL-12 genetic immunotherapy for lung cancer | 1999 (Cycle 8) | $75,000 |
| University of California, Los Angeles | Inno Dev & Exp Awards (IDEAS) | |
| A retroviral link to human tobacco-related lung cancer? | 1999 (Cycle 8) | $74,500 |
| University of California, Los Angeles | Inno Dev & Exp Awards (IDEAS) | |
| Role of protein phosphatase 2A in lung cancer | 1999 (Cycle 8) | $307,522 |
| University of California, San Diego | Research Project Awards | |
| Targeted blood clotting therapy for lung cancer | 1999 (Cycle 8) | $350,851 |
| University of Southern California | New Investigator Awards | |
| Monitoring exposure to tobacco-specific nitrosamines | 1999 (Cycle 8) | $74,999 |
| University of California, Riverside | Inno Dev & Exp Awards (IDEAS) | |
| Effects of passive smoking and pregnancy | 1999 (Cycle 8) | $565,186 |
| Lawrence Livermore National Laboratory | Research Project Awards | |
| Vascular targeting of lung tumors | 1999 (Cycle 8) | $899,686 |
| Sidney Kimmel Cancer Center | Research Project Awards | |
| Study of novel metastasis inhibitors in lung cancer | 1999 (Cycle 8) | $69,208 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Importance of Rce1 and Ras in tobacco-induced cancers | 1999 (Cycle 8) | $75,209 |
| J. David Gladstone Institutes | Postdoctoral Fellowship Awards | |
| Co-regulator mechanisms in lung cancer | 1999 (Cycle 8) | $38,267 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
1998 (Cycle 7)
| Studies of novel antitumor agents for lung cancers | 1998 (Cycle 7) | $306,000 |
| University of California, San Diego | Research Project Awards | |
| Discovery of serum markers of lung cancer | 1998 (Cycle 7) | $120,300 |
| Cedars-Sinai Medical Center | Inno Dev & Exp Awards (IDEAS) | |
| A study of Bax, a gene involved in killing tumor cells | 1998 (Cycle 7) | $75,060 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Functional significance of the protein CD40 in lung cancer | 1998 (Cycle 7) | $35,000 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Genetic susceptibility to tobacco-induced lung cancer | 1998 (Cycle 7) | $406,120 |
| University of California, Los Angeles | Research Project Awards | |
| Early detection of oral cancer | 1998 (Cycle 7) | $74,901 |
| University of California, Irvine | Inno Dev & Exp Awards (IDEAS) | |
| Isolation of lung tumor proteins for a novel treatment | 1998 (Cycle 7) | $75,000 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
| BAG-1, a unique gene involved in smoking-associated cancers | 1998 (Cycle 7) | $75,060 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Boosting the immune response against lung cancer | 1998 (Cycle 7) | $70,000 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| Developing new vaccines for lung cancer | 1998 (Cycle 7) | $398,511 |
| University of California, Los Angeles | Research Project Awards | |
| Toxic compounds targeted to lung tumor blood vessels | 1998 (Cycle 7) | $144,300 |
| The Burnham Institute for Medical Research | Inno Dev & Exp Awards (IDEAS) | |
| Dissecting signaling pathways to test cancer-killing agents | 1998 (Cycle 7) | $69,694 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| TGF-a: we need it, but too much is bad | 1998 (Cycle 7) | $69,967 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Inflammatory compounds:role in tobacco-related lung disease | 1998 (Cycle 7) | $447,367 |
| University of California, San Diego | Research Project Awards | |
| Suppressor genes of lung cancer | 1998 (Cycle 7) | $859,254 |
| The Burnham Institute for Medical Research | Research Project Awards | |
1997 (Cycle 6)
| Novel imaging methods for diagnosing tobacco related cancers | 1997 (Cycle 6) | $629,087 |
| Stanford University | Research Project Awards | |
| Tobacco-related cancer prevention by Vitamin A derivatives | 1997 (Cycle 6) | $149,947 |
| Molecular Medicine Research Institute | Research Project Awards | |
| Role of viral-derived genes in lung cancer | 1997 (Cycle 6) | $375,800 |
| Sidney Kimmel Cancer Center | New Investigator Awards | |
| A novel lung tumor suppressor | 1997 (Cycle 6) | $144,788 |
| The Burnham Institute for Medical Research | Inno Dev & Exp Awards (IDEAS) | |
| How does cigarette smoke induce cancer? | 1997 (Cycle 6) | $811,518 |
| Beckman Research Institute of the City of Hope | Research Project Awards | |
| Tobacco-related cancer prevention by Vitamin A derivatives | 1997 (Cycle 6) | $274,488 |
| SRI International | Research Project Awards | |
| Bioactive lipids in tobacco related lung cancers | 1997 (Cycle 6) | $74,496 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
| Does nicotine alter intercellular communication pathways? | 1997 (Cycle 6) | $68,864 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Development of a blood test for pancreatic cancer | 1997 (Cycle 6) | $308,819 |
| Stanford University | Research Project Awards | |
| Novel therapy for pancreatic cancer | 1997 (Cycle 6) | $452,332 |
| University of California, Irvine | Research Project Awards | |
| Does nicotine inhibit anticancer activities of Vitamin A? | 1997 (Cycle 6) | $788,808 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Role of immune defenses in lung cancer therapy | 1997 (Cycle 6) | $75,000 |
| University of California, San Francisco | Inno Dev & Exp Awards (IDEAS) | |
| Role of intracellular signals in tobacco-related disease | 1997 (Cycle 6) | $69,600 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
1995 (Cycle 4)
| Developmental Relationship between NK and T-Cell Lineages | 1995 (Cycle 4) | $434,126 |
| California Institute of Technology | Research Project Awards | |
| Membrane Signaling Pathways of RAS/RAB Proteins | 1995 (Cycle 4) | $574,559 |
| Scripps Research Institute | Research Project Awards | |
| Transcriptional Regulation of Programmed Cell Dealth | 1995 (Cycle 4) | $304,418 |
| University of California, Berkeley | Research Project Awards | |
| A New Approach for Studying the Mechanism of Squamous Metapl | 1995 (Cycle 4) | $75,000 |
| University of California, Los Angeles | Inno Dev & Exp Awards (IDEAS) | |
| Isolation of a Tumor Promoter Induced C-Fos Kinase | 1995 (Cycle 4) | $55,000 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Role of Ah Receptor Nuclear Translocator in Carcinogenesis | 1995 (Cycle 4) | $140,096 |
| University of California, Los Angeles | Research Project Awards | |
| Role in Associated Proteins in TGF-B Receptor Signalling | 1995 (Cycle 4) | $29,990 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Proteolytic Maturation of Ras & Yeast a-Factor | 1995 (Cycle 4) | $65,000 |
| University of California, Berkeley | Postdoctoral Fellowship Awards | |
| NMR Study of 13C Edatrexate Metabolism | 1995 (Cycle 4) | $258,990 |
| University of California, Davis | Research Project Awards | |
| Function and Regulation of the Retinoblastoma Protein | 1995 (Cycle 4) | $385,031 |
| University of California, San Diego | Research Project Awards | |
| Identification on Tumors of Molecular Targets for NK Cells | 1995 (Cycle 4) | $314,006 |
| University of California, San Francisco | Research Project Awards | |
| Structure-Function Correlations for Ras p21 and its Mutants | 1995 (Cycle 4) | $322,049 |
| University of Southern California | Research Project Awards | |
| Cloning of a Lung Tumor Transport Gene for Drug Development | 1995 (Cycle 4) | $104,966 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
| Tumor-Specific Vascular Proteins in Lung Cancer | 1995 (Cycle 4) | $105,294 |
| University of California, San Diego | Research Project Awards | |
| Preneoplastic Lesions and Polarity Changes in Lung Epithelia | 1995 (Cycle 4) | $142,731 |
| The Burnham Institute for Medical Research | Inno Dev & Exp Awards (IDEAS) | |
| Function of Rb-interacting zinc-finger protein, "RIZ" | 1995 (Cycle 4) | $13,665 |
| Sidney Kimmel Cancer Center | Postdoctoral Fellowship Awards | |
| Suppression of Oncogenic Ras Mutations | 1995 (Cycle 4) | $348,032 |
| University of California, Berkeley | Research Project Awards | |
| SAR Studies of Novel antitumor Agents for Lung Carcinomas | 1995 (Cycle 4) | $403,338 |
| University of California, San Diego | Research Project Awards | |
| Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro | 1995 (Cycle 4) | $321,199 |
| University of California, San Diego | Research Project Awards | |
| Role of Protein Phosphatases in Lung Cancer | 1995 (Cycle 4) | $363,234 |
| University of Southern California | New Investigator Awards | |
| Targeted Delivery of p53 to Lung Carcinoma Cells | 1995 (Cycle 4) | $143,150 |
| Sidney Kimmel Cancer Center | Inno Dev & Exp Awards (IDEAS) | |
| H-Ras Ribozyme Mediated Tumor Suppression of BUX Cells | 1995 (Cycle 4) | $352,183 |
| City of Hope National Medical Center | Research Project Awards | |
| Growth Factor Receptor Activation by Papillomavirus Proteins | 1995 (Cycle 4) | $63,439 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Function of Rb-interacting zinc-finger protein, "RIZ" | 1995 (Cycle 4) | $32,400 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
1994 (Cycle 3)
| Autocrine Interactions Between Bombesin and its Receptor | 1994 (Cycle 3) | $316,238 |
| University of California, San Diego | Research Project Awards | |
| Mechanism of Mitotic Chromosome Condensation | 1994 (Cycle 3) | $292,842 |
| University of California, San Francisco | Research Project Awards | |
| Role of aV Integrins in Malignancy of Tobacco/Induced Tumors | 1994 (Cycle 3) | $485,909 |
| Scripps Research Institute | Research Project Awards | |
| Retinoblastoma Protein Dephosphorylation in Lung Cancer | 1994 (Cycle 3) | $250,223 |
| Childrens Hospital, Los Angeles | New Investigator Awards | |
| Tumor-Specific Vascular Proteins in Lung Cancer | 1994 (Cycle 3) | $75,000 |
| University of California, San Diego | Inno Dev & Exp Awards (IDEAS) | |
| p53 Mutations in Sporadic & Familial Childhood Tumors | 1994 (Cycle 3) | $213,407 |
| University of California, Davis | New Investigator Awards | |
| Signal Transduction by TGF-d Precursor During Transformation | 1994 (Cycle 3) | $69,110 |
| University of California, San Francisco | Postdoctoral Fellowship Awards | |
| Response of Respiratory Cancers to Novel Antiofolates | 1994 (Cycle 3) | $175,926 |
| University of Southern California | Research Project Awards | |
| Periodic Gene Expression in the G1 Phase of the Cell Cycle | 1994 (Cycle 3) | $498,844 |
| California Institute of Technology | Research Project Awards | |
| Tobacco Smoking & Genetic Alterations in Bladder Epithelium | 1994 (Cycle 3) | $282,853 |
| University of California, San Francisco | Research Project Awards | |
| Environmental Tobacco Smoke and Lung Cancer | 1994 (Cycle 3) | $234,432 |
| University of California, Davis | Research Project Awards | |
| Direct Analysis of Lung Cancer Development & Progression | 1994 (Cycle 3) | $336,973 |
| University of Southern California | New Investigator Awards | |
| T-Cell Stimulating Antigen Genes in Tumor Cells | 1994 (Cycle 3) | $362,814 |
| University of California, Berkeley | Research Project Awards | |
| Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis | 1994 (Cycle 3) | $175,409 |
| Stanford University | New Investigator Awards | |
| Retinoid X Receptors in Oncogenesis | 1994 (Cycle 3) | $75,600 |
| Salk Institute for Biological Studies | Postdoctoral Fellowship Awards | |
| MDMI a Gene Involved in Yeast Mitochondrial Inheritance | 1994 (Cycle 3) | $70,000 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Signal Transduction and Cell Activation | 1994 (Cycle 3) | $404,312 |
| Salk Institute for Biological Studies | Research Project Awards | |
| Radioimmunotherapy of Lung Cancer | 1994 (Cycle 3) | $318,994 |
| University of Southern California | Research Project Awards | |
| Effects of Tobacco Smoke on Proto-Oncogene Activity | 1994 (Cycle 3) | $382,758 |
| University of California, San Diego | Research Project Awards | |
| Diagnosis and Treatment of MTAse-Deficient Lung Cancers | 1994 (Cycle 3) | $370,631 |
| University of California, San Diego | Research Project Awards | |
| Role of Protein Phosphatase 2A in Lung Carcinoma | 1994 (Cycle 3) | $342,144 |
| University of California, San Diego | Research Project Awards | |
| Serum Free Fatty Acid Levels in Patients with Malignancies | 1994 (Cycle 3) | $107,728 |
| Medical Biology Institute | Inno Dev & Exp Awards (IDEAS) | |
| Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma | 1994 (Cycle 3) | $389,719 |
| University of California, San Francisco | Research Project Awards | |
| Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis | 1994 (Cycle 3) | $43,318 |
| University of California, San Francisco | New Investigator Awards | |
| Isolation/Oncogene-activated cJun Kinase Linking Ras to AP-1 | 1994 (Cycle 3) | $53,750 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Cell Cycle Regulation of Proliferation Genes | 1994 (Cycle 3) | $32,400 |
| California Institute of Technology | Postdoctoral Fellowship Awards | |
| Radioimmunotherapy & Hypoxic Cytotoxin in Squamous Cancer | 1994 (Cycle 3) | $157,321 |
| SRI International | Research Project Awards | |
1993 (Cycle 2)
| The Role of the Macrophage in Lung Cancer | 1993 (Cycle 2) | $215,007 |
| University of California, Los Angeles | New Investigator Awards | |
| Detection of Lung Cancer Micrometastases | 1993 (Cycle 2) | $120,346 |
| University of Southern California | Inno Dev & Exp Awards (IDEAS) | |
| Involvement of RAS and Krev-1 in Lung Cancer | 1993 (Cycle 2) | $50,552 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Structure-function studies of RAS nucleotide-exchange-factor | 1993 (Cycle 2) | $593,460 |
| University of Southern California | Research Project Awards | |
| Analysis of Retinoid Mediated Anti-cancer Activities | 1993 (Cycle 2) | $757,415 |
| The Burnham Institute for Medical Research | Research Project Awards | |
| Sucellular Localization of CAMP-dependent Protein Kinase | 1993 (Cycle 2) | $338,472 |
| University of California, San Diego | Research Project Awards | |
| Molecular Basis of Lung Cancer Metastasis | 1993 (Cycle 2) | $225,093 |
| University of California, San Francisco | New Investigator Awards | |
| Novel Hypoxic Cytotoxins To Enhance Lung Cancer Radiotherapy | 1993 (Cycle 2) | $152,412 |
| SRI International | Inno Dev & Exp Awards (IDEAS) | |
| Targeting of SCLC myc mRNA by Photoactivatable DNA Probes | 1993 (Cycle 2) | $108,353 |
| Beckman Research Institute of the City of Hope | Inno Dev & Exp Awards (IDEAS) | |
| Homeobox Genes Hematopoiesis and Leukemogenesis | 1993 (Cycle 2) | $70,000 |
| University of California, Los Angeles | Postdoctoral Fellowship Awards | |
| Phosphoryl Peptide Inhibitors of Tyrosine Kinases | 1993 (Cycle 2) | $308,697 |
| University of California, San Francisco | Research Project Awards | |
| Oral Cancer: Adhesive Interactions During Progression | 1993 (Cycle 2) | $182,765 |
| University of California, San Francisco | Research Project Awards | |
| Smoking and Leukemia: A Molecular Genetic Approach | 1993 (Cycle 2) | $334,253 |
| University of California, Los Angeles | Research Project Awards | |
| Tumor Specific Antibodies | 1993 (Cycle 2) | $224,974 |
| University of California, Davis | New Investigator Awards | |
| Selective Lung Tumor Inhibition With 4-Ipomeanol Analogs | 1993 (Cycle 2) | $126,499 |
| Scripps Research Institute | Inno Dev & Exp Awards (IDEAS) | |
| Detection of Lung Tumor Derived DNA in Sputum Using PCR | 1993 (Cycle 2) | $115,098 |
| University of Southern California | Inno Dev & Exp Awards (IDEAS) | |
| Ras Prenylation, Cholesterol Biosynthesis and Lung Cancer | 1993 (Cycle 2) | $49,960 |
| The Burnham Institute for Medical Research | Postdoctoral Fellowship Awards | |
| Expression of a drug resistance gene in head and neck cancer | 1993 (Cycle 2) | $337,086 |
| University of California, San Diego | Research Project Awards | |
| Advances in Lung Cancer Detection with Digital Techniques | 1993 (Cycle 2) | $276,730 |
| University of California, Los Angeles | Research Project Awards | |
| Asymmetric Synthesis of (-)-Podophyllotoxin | 1993 (Cycle 2) | $121,946 |
| University of California, Santa Cruz | Research Project Awards | |
1992 (Cycle 1)
| The Role of Tobacco Smoke in Multi-Step Carcinogenesis | 1992 (Cycle 1) | $341,730 |
| Childrens Hospital, Los Angeles | New Investigator Awards | |
| NMYC Oncogene Expression in Small Cell Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, Los Angeles | New Investigator Awards | |
| Cigarette Smoke Induced Changes in Gene Expression | 1992 (Cycle 1) | $222,046 |
| University of California, Davis | New Investigator Awards | |
| Neutrophil Cytostatic Activity Against Lung Tumor Cells | 1992 (Cycle 1) | $223,628 |
| University of California, Los Angeles | Research Project Awards | |
| Retinoic Acid Receptor Expression in Human Lung Cancer | 1992 (Cycle 1) | $204,590 |
| University of California, Los Angeles | New Investigator Awards | |
| Lung Cancer: p53 as a Paradigm of Tumor Suppression | 1992 (Cycle 1) | $327,795 |
| University of California, Los Angeles | Research Project Awards | |
| Analysis of RAS Mutations in the Canine Smoking Model | 1992 (Cycle 1) | $70,000 |
| University of California, Davis | Postdoctoral Fellowship Awards | |
| Molecular Studies of NNK-Induced Lung Tumors in Hamsters | 1992 (Cycle 1) | $35,000 |
| University of California, Davis | Postdoctoral Fellowship Awards | |
| Involvement of the Tumor Suppressor Gene p53 in Lung Cancer | 1992 (Cycle 1) | $112,504 |
| University of California, Irvine | Research Project Awards | |
| Integrin Distribution & Function in Lung Carcinoma Cells | 1992 (Cycle 1) | $358,128 |
| University of California, San Francisco | Research Project Awards | |
| Tumor Infiltrating Lymphocytes & Pulmonary Macrophages | 1992 (Cycle 1) | $423,786 |
| University of California, Los Angeles | Research Project Awards | |
| Novel Approach to Head & Neck Cancer Therapy | 1992 (Cycle 1) | $384,743 |
| University of Southern California | Research Project Awards | |
| Vaccine Strategy Against Tumor-Associated Glycoproteins | 1992 (Cycle 1) | $285,227 |
| University of California, San Diego | Research Project Awards | |
| Characterization of a New Tumor Suppressor Gene | 1992 (Cycle 1) | $200,810 |
| University of California, San Diego | New Investigator Awards | |
| Studies in Genotoxicity of Tobacco-Related Carcinogens | 1992 (Cycle 1) | $288,000 |
| The Burnham Institute for Medical Research | New Investigator Awards | |
| Tobacco-Related Carcinogens in Human Epithelial Cells | 1992 (Cycle 1) | $224,999 |
| Lawrence Berkeley National Laboratory | New Investigator Awards | |
| Tumor Models & Radioimmunotherapy of Human Lung Cancers | 1992 (Cycle 1) | $202,062 |
| City of Hope National Medical Center | New Investigator Awards | |
| Tobacco Carcinogens/C-Kinase Oxidative Activation/Metastasis | 1992 (Cycle 1) | $363,557 |
| University of Southern California | Research Project Awards | |
| Tobacco Smoke, Benzene, & Mechanisms of Leukemogenesis | 1992 (Cycle 1) | $224,492 |
| University of California, Riverside | New Investigator Awards | |
| Drug Resistance During Induction Chemotherapy for Lung Cancer | 1992 (Cycle 1) | $31,874 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Tobacco Carcinogen Transformation of Human Bronchial Cells | 1992 (Cycle 1) | $621,592 |
| University of Southern California | Research Project Awards | |
| Role of Jun Family of Proto-Oncogenes in Lung Cancer | 1992 (Cycle 1) | $68,400 |
| University of California, San Diego | Postdoctoral Fellowship Awards | |
| Lung Cancer Associated Retinopathy | 1992 (Cycle 1) | $352,945 |
| University of California, Davis | Research Project Awards | |
| Cloning of Two Genes Involved it Tobacco Carcinogenesis | 1992 (Cycle 1) | $323,634 |
| University of California, Los Angeles | Research Project Awards | |
| Studies of Proto-oncogenes & Growth Genes in Human Lung Cancer | 1992 (Cycle 1) | $336,209 |
| University of California, Los Angeles | Research Project Awards | |
| Significance of Immune Complexes in Human Lung Carcinoma | 1992 (Cycle 1) | $249,402 |
| John Wayne Cancer Institute | Research Project Awards | |
| Gene Modification of Human Lung Tumor-Infiltrating Lymphocyte | 1992 (Cycle 1) | $152,816 |
| University of California, Los Angeles | Research Project Awards | |
| Local Cytokine Immunotherapy for Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, Los Angeles | New Investigator Awards | |
| Stem Cell Transplantation for Small & Non-small Cell Lung Cancers | 1992 (Cycle 1) | $174,666 |
| University of California, Los Angeles | New Investigator Awards | |
| Tumor Suppressor Gene Mutations in Lung Cancer | 1992 (Cycle 1) | $333,054 |
| University of Southern California | New Investigator Awards | |
| Tumor Models & Radioimmunotherapy of Human Lung Cancers | 1992 (Cycle 1) | $12,382 |
| University of Southern California | New Investigator Awards | |
| Lung Cancer: p53 as a Paradigm of Tumor Suppression | 1992 (Cycle 1) | $138,420 |
| Cedars-Sinai Medical Center | Research Project Awards | |
| Preclinical Studies of Novel Agents for Lung Cancer | 1992 (Cycle 1) | $225,000 |
| University of California, San Diego | New Investigator Awards | |
| Glutathione Transferase in Lung Cancer: Transfection Studies | 1992 (Cycle 1) | $67,732 |
| Stanford University | Postdoctoral Fellowship Awards | |
| Genetic Aberrations in Tobacco-Related Lung Carcinogenesis | 1992 (Cycle 1) | $214,126 |
| University of Southern California | Research Project Awards | |
| Monoclonal Antibody-Drug Conjugate Treatment of Lung Cancer | 1992 (Cycle 1) | $258,750 |
| Scripps Clinic & Research Foundation | Research Project Awards | |
| Tumor Suppressor Genes in Human Lung Cancer | 1992 (Cycle 1) | $319,060 |
| University of California, Irvine | Research Project Awards | |
| Early Detection of Lung Cancer with Monoclonal Antibodies | 1992 (Cycle 1) | $860,784 |
| University of California, Los Angeles | Research Project Awards | |
| Novel Imuunotherapy for Small Cell Lung Carcinoma | 1992 (Cycle 1) | $496,569 |
| Childrens Hospital, Los Angeles | Research Project Awards | |
| Suppression of Oncogenic RAS Mutations | 1992 (Cycle 1) | $355,159 |
| University of California, Berkeley | Research Project Awards | |